Respiratory illnesses, including COVID-19, influenza, and RSV, are surging across the United States, with healthcare systems feeling the strain as more people seek care for these conditions.

A single dose of respiratory syncytial virus vaccine was effective against infections and associated hospitalizations in veterans aged at least 60 years during the 2023-24 season.